Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

AG938

Sigma-Aldrich

Synuclein, α, recombinant human

Synonyme(s) :

α-Synuclein protein, Alpha Synuclein

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12352200
eCl@ss :
32160405
Nomenclature NACRES :
NA.41

Source biologique

human

Niveau de qualité

Pureté

>95% (gel scan and mass spectrometry)

Forme

solid

Durée de conservation

12 mo.

Fabricant/nom de marque

Chemicon®

Solubilité

water: slightly soluble

Adéquation

suitable for molecular biology

Numéro d'accès NCBI

Numéro d'accès UniProt

Informations sur le gène

human ... SNCA(6622)

Description générale

Research area: Neuroscience

α-Synuclein, a member of the synuclein family of proteins that localize to presynaptic terminals under physiological conditions. It is comprised of three primary regions: an amino terminus containing apolipoprotein lipid-binding motifs, which are anticipated to form amphiphilic helices. The central region, known as non-Aβ component (NAC) containing a hydrophobic domain that gives β-sheet potential, and the carboxyl terminus, characterized by a high negative charge and remains unstructured. Under physiological conditions, members of the synuclein family, including α-synuclein, are predominantly neuronal proteins.

Application

Synuclein, α, recombinant human has been used:
  • for preparation of α-synuclein fibrils to access the SAR228810 antibody against the risk of amyloid-related imaging abnormalities (ARIA).
  • to study the formation of isoasparate protein damage responsible to trigger familial Parkionsonian phenotypes.
  • to study its interaction with iron and copper, in order to understand their role in proteinopathies.

Actions biochimiques/physiologiques

Synuclein, α is the principal component of Lewy bodies and a pathological hallmark of synucleinopathies, including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). The deposition of αS aggregates is a defining characteristic of all these diseases.

Forme physique

Lyophilized from TBS. Resuspend in water at a concentration of 1 mg/mL.

Stockage et stabilité

Maintain lyophilized material at -20ºC for up to 12 months after date of receipt. After reconstitution maintain at -20ºC to -70ºC for up to 2 weeks in undiluted aliquots. Avoid freeze/thaw cycles to avoid aggregation.

Informations légales

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Code de la classe de stockage

13 - Non Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Molecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms
Vigneswara V, et al.
PLoS ONE, 8(4), e61442-e61442 (2013)
SAR228810: an antibody for protofibrillar amyloid ? peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)
Pradier L, et al.
Alzheimer's Research & Therapy, 10(1), 117-117 (2018)
The many faces of ?-synuclein: from structure and toxicity to therapeutic target
Lashuel HA, et al.
Nature Reviews. Neuroscience, 14, 38-48 (2013)
Emerging Approaches to Investigate the Influence of Transition Metals in the Proteinopathies
Lermyte F, et al.
Cells, 8(10), 1231-1231 (2019)
Alpha-synuclein structure and Parkinson?s disease ? lessons and emerging principles
Meade RM, et al.
Mol. Neurodegener., 14 (2019)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique